Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Gastroenterologie Clinique Et Biologique
|
February 15, 2001
[Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study]
A Tran, F Longo, M C Saint-Paul, et al.
Digestive Diseases and Sciences
|
April 1, 1997
Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment
A Tran, S Benzaken, G Yang, et al.
HIV Medicine
|
October 11, 2021
Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents
Fernanda Rick, Wilfred Odoke, Jan van den Hombergh, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Prevalence of serum anti-hepatitis E virus antibodies in patients with human immunodeficiency virus infection]
A Tran, J F Broussard, J Durant, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
January 12, 2002
HIV prevention for indigenous people of the Amazon basin
J G Linn, L Garnelo, B A Husaini, et al.
Presse Medicale (Paris, France : 1983)
|
November 18, 1995
[Anti-thyroid autoantibodies in hepatitis C. Thyroid function after interferon therapy in 4 patients]
J F Broussard, A Tran, S Benzaken, et al.
The American Journal of Gastroenterology
|
October 23, 1997
Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C
A Tran, G Yang, G Dreyfus, et al.
AIDS Research and Therapy
|
August 16, 2019
Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
Adele S Benzaken, Gerson F M Pereira, Lendel Costa, et al.
Nature Reviews. Disease Primers
|
October 13, 2017
Syphilis
Rosanna W Peeling, David Mabey, Mary L Kamb, et al.
Gastroenterologie Clinique Et Biologique
|
February 19, 2000
[Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors]
F Longo, X Hebuterne, A Tran, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Gastroenterologie Clinique Et Biologique
|
February 15, 2001
[Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study]
A Tran, F Longo, M C Saint-Paul, et al.
Digestive Diseases and Sciences
|
April 1, 1997
Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment
A Tran, S Benzaken, G Yang, et al.
HIV Medicine
|
October 11, 2021
Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continents
Fernanda Rick, Wilfred Odoke, Jan van den Hombergh, et al.
Gastroenterologie Clinique Et Biologique
|
January 1, 1997
[Prevalence of serum anti-hepatitis E virus antibodies in patients with human immunodeficiency virus infection]
A Tran, J F Broussard, J Durant, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
January 12, 2002
HIV prevention for indigenous people of the Amazon basin
J G Linn, L Garnelo, B A Husaini, et al.
Presse Medicale (Paris, France : 1983)
|
November 18, 1995
[Anti-thyroid autoantibodies in hepatitis C. Thyroid function after interferon therapy in 4 patients]
J F Broussard, A Tran, S Benzaken, et al.
The American Journal of Gastroenterology
|
October 23, 1997
Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C
A Tran, G Yang, G Dreyfus, et al.
AIDS Research and Therapy
|
August 16, 2019
Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
Adele S Benzaken, Gerson F M Pereira, Lendel Costa, et al.
Nature Reviews. Disease Primers
|
October 13, 2017
Syphilis
Rosanna W Peeling, David Mabey, Mary L Kamb, et al.
Gastroenterologie Clinique Et Biologique
|
February 19, 2000
[Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors]
F Longo, X Hebuterne, A Tran, et al.
Page
of 6